Pharmacotherapy of Pediatrics suspected/confirmed COVID­19

Most children present as asymptomatic to mild/moderate disease; of those who became symptomatic 2.5% developed severe disease and only 0.2% develop critical illness. Supportive care including the use of pharmacologic agents remains the cornerstone of management. This document aims to help clinicians decide in the administration and dosage of antimicrobial drugs in children with COVID-19.

Pharmacotherapy of Pediatrics suspected/confirmed COVID-­19
Size: 136 KB